首页> 美国卫生研究院文献>BioMed Research International >Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data
【2h】

Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data

机译:通过整合PPI网络和基因表达数据预测和验证与大肠癌相关的Hub基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although hundreds of colorectal cancer- (CRC-) related genes have been screened, the significant hub genes still need to be further identified. The aim of this study was to identify the hub genes based on protein-protein interaction network and uncover their clinical value. Firstly, 645 CRC patients' data from the Tumor Cancer Genome Atlas were downloaded and analyzed to screen the differential expression genes (DEGs). And then, the Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis was performed, and PPI network of the DEGs was constructed by Cytoscape software. Finally, four hub genes (CXCL3, ELF5, TIMP1, and PHLPP2) were obtained from four subnets and further validated in our clinical setting and TCGA dataset. The results showed that mRNA expression of CXCL3, ELF5, and TIMP1 was increased in CRC tissues, whereas PHLPP2 mRNA expression was decreased. More importantly, high expression of CXCL3, ELF5, and TIMP1 was significantly associated with lymphatic invasion, distance metastasis, and advanced tumor stage. In addition, a shorter overall survival was observed in patients with increased CXCL3, TIMP1, and ELF5 expression and decreased PHLPP2 expression. In conclusion, the four hub genes screened by our strategy could serve as novel biomarkers for prognosis prediction of CRC patients.
机译:尽管已经筛选了数百种与大肠癌相关的基因,但是仍然需要进一步鉴定重要的中枢基因。这项研究的目的是基于蛋白质-蛋白质相互作用网络鉴定集线器基因,并揭示其临床价值。首先,下载并分析了645位来自肿瘤基因组图谱的CRC患者数据,以筛选差异表达基因(DEG)。然后,进行了《京都市基因与基因组百科全书》途径富集分析,并通过Cytoscape软件构建了DEGs的PPI网络。最后,从四个子网中获得了四个集线器基因(CXCL3,ELF5,TIMP1和PHLPP2),并在我们的临床环境和TCGA数据集中进行了进一步验证。结果表明,CRC组织中CXCL3,ELF5和TIMP1的mRNA表达增加,而PHLPP2的mRNA表达减少。更重要的是,CXCL3,ELF5和TIMP1的高表达与淋巴管浸润,距离转移和晚期肿瘤显着相关。此外,在CXCL3,TIMP1和ELF5表达升高而PHLPP2表达降低的患者中,观察到总体生存期较短。总之,我们的策略筛选出的四个枢纽基因可以作为预测CRC患者预后的新型生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号